This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Patel, V. Articles by Morrissey, J. Search for Related Content Social Bookmarking                         What's this?

The Alphabet Strategy

The ABC of reducing diabetes complications

Diabetes and Endocrinology Centre, George Eliot Hospital NHS Trust, College Street, Nuneaton, Warwickshire, CV10 7DJ, UK, vinod.patel@ geh-tr.wmids.nhs.uk

John Morrissey

We have no cure for diabetes but as the recently published National Service Framework for Diabetes: Standards notes `with the support of high quality healthcare, people with diabetes have the potential to live long lives free of the devastating complications suffered by previous generations`.¹ An earlier NSF, that for Coronary Heart Disease, observes that `excellence requires that important, simple things are done right all the time`.² Exactly the same maxim can be applied to diabetes care. Vinod Patel and John Morrissey outline their Alphabet Strategy — a condensed but simple mnemonic to help them get seven important, simple things right:

References

• National Service Framework for Diabetes: Standards, 2002, Department of Health.
• National Service Framework for Coronary Heart Disease, 2000, Department of Health.
• Tuomilehto J., Lindstrom J., Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among patients with impaired glucose tolerance. N Engl J Med 2001; 344:1343-50.[Abstract/Free Full Text]
• Bailey CJ The Diabetes Prevention Program: headline results. Br J Diabetes Vasc Dis 2001;1:62-4.[Abstract/Free Full Text]
• Mogensen C-E. Diabetic nephropathy: evidence for renoprotection and practice. Heart 2000;84(suppl I):i26-8.[Free Full Text]
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998;317:703-13.[Abstract/Free Full Text]
• UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39). BMJ 1998;317:713-20.[Abstract/Free Full Text]
• Pyorali K., Pedersen TR, Kjekshus J., Faergeman O., Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 1997;20:614-20.[Abstract]
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kohner E., Allwinkle J., Andrews J. et al. Saint Vincent and improving diabetes care. Report of the visual handicap group. Diabetic Med 1996:13:S13-26.[Web of Science][Medline] [Order article via Infotrieve]
• Edmonds ME, Boulton AJM, Buckingham T. et al. Report of the Diabetic Foot and Amputation Group. Diabetic Med 1996;13: S27-42.[Web of Science][Medline] [Order article via Infotrieve]
• Aspirin and diabetes. Diabetes Update Fact Sheet 21 (Summer) 2000. Diabetes UK.
• The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.[Abstract/Free Full Text]
• The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE sub-study. Lancet 2000;355:253-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.[Abstract/Free Full Text]
• Brenner BM, Cooper ME, De Zeeuw D. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345: 861-9.[Abstract/Free Full Text]
• Parving H-H., Lehnert H., Brochner-Mortensen J. et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345: 870-8.[Abstract/Free Full Text]
• Testing Times: a review of diabetes services in England and Wales. Audit Commission, 2000.

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 1, 58-59 (2002)
DOI: 10.1177/14746514020020010701


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				N. Gholap, M. Pillai, S. Virmani, J. D Lee, D. James, J. Morrissey, V. Datta, and V. Patel The Alphabet Strategy and standards of care in young adults with type 1 diabetes The British Journal of Diabetes & Vascular Disease, July 1, 2006; 6(4): 168 - 170. [Abstract] [PDF]

				P. K Jaiveer, S. Jaiveer, S. B Jujjavarapu, J. Morrissey, J. White, R. Gadsby, and V. Patel Improvements in clinical diabetes care in the first year of the new General Medical Services contract in the UK The British Journal of Diabetes & Vascular Disease, January 1, 2006; 6(1): 45 - 48. [Abstract] [PDF]

				V. Patel, O. Pedersen, J. Morrissey, H.-H. Parving, P. Gaede, and J. D. Lee The `polypill' to reduce cardiovascular risk: proof of concept: Data from the Steno-2 multifactorial intervention study in type 2 diabetes supports the `polypill' strategy to reduce cardiovascular risk The British Journal of Diabetes & Vascular Disease, September 1, 2004; 4(5): 339 - 341. [Abstract] [PDF]

				M. Kirby Type 2 diabetes within primary care The British Journal of Diabetes & Vascular Disease, March 1, 2004; 4(2): 67 - 69. [PDF]

				N. P Jagjivan, S. H Shotton, and V. Patel An unusual cause of a foot ulcer in a patient with type 1 diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2004; 4(1): 55 - 56. [PDF]

				P. Jaiveer, J. Saraswathy, J. D Lee, J. Morrissey, and V. Patel The Alphabet strategy -- a tool to achieve clinical trial standards in routine practice? The British Journal of Diabetes & Vascular Disease, November 1, 2003; 3(6): 410 - 413. [Abstract] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Patel, V. Articles by Morrissey, J. Search for Related Content Social Bookmarking                         What's this?